{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:00:16Z","timestamp":1761897616848,"version":"3.44.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.leukres.2022.106794","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T19:56:42Z","timestamp":1643745402000},"page":"106794","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Diagnostic and prognostic implications of tumor expression of the GATA-3 gene in nodal peripheral T-cell lymphoma (nPTCL): Retrospective data from a Latin American cohort"],"prefix":"10.1016","volume":"114","author":[{"given":"Lu\u00eds Alberto","family":"de P\u00e1dua Covas Lage","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e1udio Vin\u00edcius","family":"Brito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9bora","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hebert Fabr\u00edcio","family":"Culler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel Campanelli","family":"Freitas Couto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas Bassolli Alves","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Cl\u00e1udia","family":"Nogueira Zerbini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanderson","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.leukres.2022.106794_bib1","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.leukres.2022.106794_bib2","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.leukres.2022.106794_bib3","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","article-title":"Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma","volume":"123","author":"Iqbal","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2022.106794_bib4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s10147-016-1045-2","article-title":"T-cell lymphomas, a challenging disease: types, treatments and future","volume":"22","author":"MA","year":"2017","journal-title":"Int J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.leukres.2022.106794_bib5","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3109\/10428194.2013.858154","article-title":"The problem with cyclophosphamide, doxorrubicin, vincristine and prednisone for the treatment of peripheral T-cell lymphoma","volume":"55","author":"Kansara","year":"2014","journal-title":"Leuk. Lymphoma"},{"issue":"7","key":"10.1016\/j.leukres.2022.106794_bib6","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/ni.2623","article-title":"GATA-3 controls the maintenance and proliferation of T cells downstream of TCR and cytokine signaling","volume":"14","author":"Wang","year":"2013","journal-title":"Nat. Immunol."},{"issue":"7\u20138","key":"10.1016\/j.leukres.2022.106794_bib7","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.intimp.2009.03.014","article-title":"Immunoregulatory effects of sinomenine on the T-bet\/GATA-3 ratio and Th1\/Th2 cytokine balance in the treatment of mesangial proliferative nephritis","volume":"9","author":"Cheng","year":"2009","journal-title":"Int. Immunopharmacol."},{"issue":"10","key":"10.1016\/j.leukres.2022.106794_bib8","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/ni.2692","article-title":"GATA-3 regulates the self-renewal of long-term hematopoietic stem cell","volume":"14","author":"Frelin","year":"2013","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.leukres.2022.106794_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.humpath.2015.09.015","article-title":"GATA-3 and FOXA1 expression is useful to differentiate breast carcinoma from other carcinomas","volume":"47","author":"Davis","year":"2016","journal-title":"Hum. Pathol."},{"issue":"9","key":"10.1016\/j.leukres.2022.106794_bib10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.acuro.2017.03.004","article-title":"Usefulness of GATA-3 as a marker of seminal epithelium in prostate biopsies","volume":"41","author":"Ortiz-Rey","year":"2017","journal-title":"Actas Urol. Esp."},{"issue":"3","key":"10.1016\/j.leukres.2022.106794_bib11","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/PGP.0000000000000403","article-title":"Expression of GATA-3 in testicular and gynecologic mesothelial neoplastic and non-neoplastic tissues","volume":"37","author":"Ronaghy","year":"2018","journal-title":"Int J. Gynecol. Pathol."},{"issue":"50","key":"10.1016\/j.leukres.2022.106794_bib12","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.18632\/oncotarget.27098","article-title":"Proliferative, pro-inflammatory and angiogenesis regulator gene expression profile defines prognosis in different histopathological subtypes of nodal peripheral T-cell lymphoma","volume":"10","author":"de P\u00e1dua Covas Lage","year":"2019","journal-title":"Oncotarget"},{"issue":"27","key":"10.1016\/j.leukres.2022.106794_bib13","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.leukres.2022.106794_bib14","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"40","key":"10.1016\/j.leukres.2022.106794_bib15","doi-asserted-by":"crossref","first-page":"65284","DOI":"10.18632\/oncotarget.11673","article-title":"GATA3 expression correlates with poor prognosis and tumor-associated macrophage infiltration in peripheral T-cell lymphoma","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.leukres.2022.106794_bib16","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/ng.2803","article-title":"Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse","volume":"45","author":"Prez-Andreu","year":"2013","journal-title":"Nat. Genet."},{"issue":"15","key":"10.1016\/j.leukres.2022.106794_bib17","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1182\/blood-2018-09-872549","article-title":"Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphomas","volume":"133","author":"Heavican","year":"2019","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.leukres.2022.106794_bib18","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","article-title":"ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes","volume":"124","author":"Parrilla-Castellar","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2022.106794_bib19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.humpath.2018.11.005","article-title":"A combination of GATA 3 and SOX 10 is useful for diagnosis of metastatic triple-negative breast cancer","volume":"85","author":"Tozbikian","year":"2019","journal-title":"Hum. Pathol."},{"issue":"2","key":"10.1016\/j.leukres.2022.106794_bib20","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4103\/IJPM.IJPM_228_18","article-title":"Diagnostic utility of GATA3 immunohistochemical expression in urothelial carcinoma","volume":"62","author":"Agarwal","year":"2019","journal-title":"Indian J. Pathol. Microbiol."},{"issue":"4","key":"10.1016\/j.leukres.2022.106794_bib21","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41379-018-0167-7","article-title":"GATA3 immunoreactivity expands the transcription fator profile of neuroendocrine tumors","volume":"32","author":"Mete","year":"2019","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.leukres.2022.106794_bib22","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.humpath.2017.05.009","article-title":"T-cell transcription factor GATA3 is an immunophenotypic marker of acute leukemias with T-cell differentiation","volume":"65","author":"Dorfman","year":"2017","journal-title":"Hum. Pathol."},{"issue":"4","key":"10.1016\/j.leukres.2022.106794_bib23","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.bjhh.2015.03.017","article-title":"Primary nodal peripheral T-cell lymphomas: diagnosis and therapeutic considerations","volume":"37","author":"Lage","year":"2015","journal-title":"Rev. Bras. Hematol. Hemoter."},{"issue":"1","key":"10.1016\/j.leukres.2022.106794_bib24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bjhh.2015.11.002","article-title":"A difficult case of angioimmunoblastic T-cell lymphoma to diagnose","volume":"38","author":"Sachsida-Colombo","year":"2016","journal-title":"Rev. Bras. Hematol. Hemoter."},{"issue":"25","key":"10.1016\/j.leukres.2022.106794_bib25","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"25","key":"10.1016\/j.leukres.2022.106794_bib26","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1200\/JCO.2011.40.2719","article-title":"Up-front autologous stem cell transplantation in peripheral T-cell lymphoma: NLG-T-01","volume":"30","author":"d\u2019Amore","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"25","key":"10.1016\/j.leukres.2022.106794_bib27","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1182\/blood-2017-05-780049","article-title":"Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma","volume":"130","author":"Pro","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2022.106794_bib28","first-page":"1","article-title":"Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified","volume":"3705","author":"Debackere","year":"2021","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.leukres.2022.106794_bib29","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/bjh.13202","article-title":"Factors predicting survival in peripheral T-cell lymphoma in the USA: a population- based analysis of 8802 patients in the modern era","volume":"168","author":"Petrich","year":"2015","journal-title":"Br. J. Haemathol."},{"issue":"8","key":"10.1016\/j.leukres.2022.106794_bib30","first-page":"2697","article-title":"ALK+ lymphoma: clinic-pathological findings and outcomes","volume":"93","author":"Fallini","year":"1999","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.leukres.2022.106794_bib31","first-page":"2993","article-title":"Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T\/null cell phenotype","volume":"96","author":"Suzuki","year":"2000","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.leukres.2022.106794_bib32","doi-asserted-by":"crossref","first-page":"e562","DOI":"10.3324\/haematol.2018.213512","article-title":"ALK-positive anaplastic large-cell lymphoma in adults: an individual patient data pooled analysis of 263 patients","volume":"104","author":"Sibon","year":"2019","journal-title":"Haematologica"},{"issue":"32","key":"10.1016\/j.leukres.2022.106794_bib33","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1200\/JCO.2012.42.2345","article-title":"Long-term outcome of adults with anaplastic large-cell lymphoma treated within the Groupe d\u2019Etude des Lymphomes de l\u2019adulte trials","volume":"30","author":"Sibon","year":"2012","journal-title":"J. Clin. Oncol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212622000200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212622000200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:01:55Z","timestamp":1758934915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212622000200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":33,"alternative-id":["S0145212622000200"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2022.106794","relation":{},"ISSN":["0145-2126"],"issn-type":[{"type":"print","value":"0145-2126"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic and prognostic implications of tumor expression of the GATA-3 gene in nodal peripheral T-cell lymphoma (nPTCL): Retrospective data from a Latin American cohort","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2022.106794","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106794"}}